Clinical Trial Update: Paclitaxel in Treating Patients With Ovarian Stromal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating paclitaxel for ovarian stromal tumors; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Granulosa Cell Tumor
• Ovarian Gynandroblastoma
• Ovarian Sertoli-leydig Cell Tumor
• Ovarian Sex Cord-stromal Tumor
• Ovarian Steroid Cell Tumor

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Adult Type Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-05